Bimatoprost eyelash treatment will drop next summer
The FDA pulled growth-stimulating eyelash treatments earlier this year, worried that the prescription-grade drugs contained in the products would cause safety issues. Since then, Allergan has conducted successful clinical trials on a prescription cosmetic drug that actually makes your eyelashes longer and thicker. FDA approval is pending, but the currently unnamed product is expected to be available sometime next summer.
This product is unlike Jan Marini’s Marini Lash, an over-the-counter product that contains vitamins, peptides, moisturizers and plant extracts. Allergan’s product contains bimatoprost, an active ingredient contained in Lumigan — the company’s glaucoma medication. When Lumigan came out, doctors noticed that patients who were applying the medication with an eye dropper were beginning to develop longer, thicker and darker eyelashes as a side effect. Allergan then decided to bottle the bimatoprost for cosmetic uses. The product comes in a tube, identical to a mascara tube, and is applied with a wand like liquid eyeliner.
Many similar products exist on the market, such as Revitalash and Jan Marini’s Age Intervention Eyelash Conditioner. DermaLash recently launched its eyelash conditioner in black, cocoa, indigo and plum so that the product can be worn during the day like makeup. None of these products, however, actually makes eyelashes grow. They work by conditioning the lashes and making them healthier. If you’re willing to shell out about $150 for any of these products, they’re definitely worth it. Someone gave me a tube of Revitalash about six months ago, and my eyelashes appeared longer in about two weeks.
Some people remain worried about potential side effects. But I can’t wait to get Allergan’s product next summer. If it’s good enough for the FDA, it’s good enough for me.